Nel ASA's 1.3 Billion NOK Backlog Faces a Critical Conversion Test
Published on 04/16/2026 at 16:02 | Redaktion boerse-global.de
Investors in Norwegian electrolyser manufacturer Nel ASA are demanding proof. The company’s order backlog has swelled to over 1.3 billion Norwegian Kroner (NOK), yet revenue from customer contracts fell sharply last quarter. This glaring paradox sets the stage for a pivotal first-quarter report on April 22, a release that will test the market’s fading patience with the green hydrogen pioneer.
The core issue is a staggering disconnect between orders and income. In the fourth quarter of 2025, order intake in Nel’s PEM segment exploded by 364% to NOK 686 million. Simultaneously, revenue from those customer contracts collapsed by 20%. For the full year 2025, the company posted a net loss of NOK 1.27 billion, weighed down by significant one-off impairments, while total revenue declined by 31%. Management has pointed to irregular delivery schedules for major projects, but analysts are growing skeptical of the narrative.
This skepticism is reflected in subdued ratings across the board. Berenberg analyst James Carmichael highlights the unpredictable pace of order conversion as a fundamental concern. His firm maintains a "Hold" rating, recently trimming its price target to NOK 2.30. Citi follows a similar line with a "Hold" and a NOK 2.40 target. The consensus price target sits at NOK 2.14. Notably, not a single analyst currently recommends buying the stock, with seven advising investors to sell. The primary doubts center on the commercial readiness of Nel’s new technology and the weak translation of bookings into sales.
All strategic hopes are pinned on that new technology platform. Nel plans a commercial launch of its "Next Generation Pressurized Alkaline" electrolyser system in the first half of 2026. The company claims the system could be up to 60% cheaper to manufacture than current models. EU grant funding of up to €135 million supports the initiative, covering approximately 60% of eligible costs. The initial investment for one gigawatt of production capacity is estimated at around NOK 300 million before subsidies, with mass deliveries slated for 2027.
Should investors sell immediately? Or is it worth buying Nel ASA?
This technological pivot, however, creates a costly parallel problem. At the Herøya site, two legacy 500-megawatt production lines stand idle. Management is currently reviewing their book values, and a decision on reactivation, sale, or permanent closure is pending. A complete write-down would deliver another blow to the already strained balance sheet, posing a tangible risk of a further impairment shock in the near term.
Financially, Nel enters this transition with a liquidity reserve of approximately NOK 1.6 billion, capital it states is fully earmarked for the technology shift. While this provides a buffer, persistent cash burn raises questions about long-term financial stability. The upcoming report is also the first test of a newly implemented executive compensation program that directly ties management pay to financial performance.
Despite the fundamental challenges, the stock has shown recent resilience. Shares currently trade around €0.21, having gained over 9% in the past week to push back above the 50-day moving average of €0.19. This leaves the price roughly 17% below its 52-week high from July 2025.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
The April 22 report must deliver concrete answers. The market needs to see how much of the late-2025 order boom is converting into recognized revenue and gain clarity on potential asset write-downs at Herøya. External factors like tightening global decarbonization rules and the evolution of US green energy tax credits may fuel long-term demand, but for now, the focus is purely on execution. The subsequent half-year report on July 15 will then serve as the next strict milestone for Nel’s promised operational turnaround.
Ad
Nel ASA Stock: New Analysis - 16 April
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
